APITX
Price
$16.33
Change
-$0.13 (-0.79%)
Updated
Jul 10 closing price
Net Assets
125.07M
RSLEX
Price
$82.59
Change
-$0.07 (-0.08%)
Updated
Jul 10 closing price
Net Assets
94.26B
Interact to see
Advertisement

APITX vs RSLEX

APITX vs RSLEX Comparison Chart in %
View a ticker or compare two or three
VS
APITX vs. RSLEX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APITX is a StrongBuy and RSLEX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLEX has more cash in the bank: 94.3B vs. APITX (125M). RSLEX pays higher dividends than APITX: RSLEX (0.59) vs APITX (0.00). APITX was incepted earlier than RSLEX: APITX (41 years) vs RSLEX (24 years). APITX (2.28) is less costly to investors than RSLEX (1.00). RSLEX is a more actively managed with annual turnover of: 41.00 vs. APITX (38.00). RSLEX has a lower initial minimum investment than APITX: RSLEX (250) vs APITX (1000). APITX annual gain was more profitable for investors over the last year : 25.42 vs. RSLEX (13.79). APITX return over 5 years is better than : 7.43 vs. RSLEX (-4.03).
APITXRSLEXAPITX / RSLEX
Total Expense Ratio2.261.00226%
Annual Report Gross Expense Ratio2.281.00228%
Fund Existence41 years24 years-
Gain YTD17.14512.037142%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets125M94.3B0%
Annual Yield % from dividends0.000.59-
Returns for 1 year25.4213.79184%
Returns for 3 years43.6230.08145%
Returns for 5 years7.43-4.03-184%
Returns for 10 years27.5887.4432%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FKINX2.55N/A
N/A
Franklin Income A1
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
GSMQX19.96N/A
N/A
Goldman Sachs Small/Mid Cap Growth Svc
BDBKX32.32N/A
N/A
iShares Russell 2000 Small-Cap Idx K
MCYAX16.20-0.50
-2.99%
NYLI Candriam Emerging Markets Eq Cl A